InMed Pharmaceuticals Inc (INM)

[Aladdin80]

It's obviously going to get worse in the near-term and one would have to have blinders on to think otherwise. Even if they didn't hit the brickwall on biosynthesis last yr they would still have required a cash injection prior to any revs coming online. The timing never lined up.

Unless they can pull off a non-dilutive raise like their industry peer TBP it's almost certain this next round of financing will almost certainly crush them and their shareholders. A non-dilutive option is unlikely as they don't have one mature product in their pipeline to offer via a royalty/licensing model. License what? They're running out of mojo and they'll need an incredibly high number of new shares issued only to raise a few bucks at current levels. Between Q4/19 and Q1/20 it's looking like they're going from bad to worse rather quickly.